Abstract
This is a short summary of the literature on local cerebral glucose metabolism in movement disorders as studied with PET and the 18F-fluorodeoxyglucose technique. For a comprehensive review of PET findings in movement disorders, including changes in flow, oxygen and glucose metabolism, as well as neurotransmitter changes, the reader is referred to a recently published monograph (Leenders, 1986).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albert, M.L. 1978. Alzheimer’s disease: Senile dementia and related disorders. In “Aging”, Vol. 7.(Eds. R. Katzman, R.D. Terry and K.L. Bick). (Raven Press, New York), pp. 173–180.
Hawkins, R.A., Phelps, M.E., Mazziotta, J.C., et al. 1983. A study of Wilson’s disease with 18-F FDG and positron tomography. J. Cereb. Blood Flow Metab., 3 (Suppl. 1), 498–499.
Heiss, W.-D., Beil, C., Herholz, K., et al. (Eds.) 1985. Atlas of Positron Emission Tomography of the Brain. (Springer Verlag, Berlin-Heidelberg-New York).
Kühl, D.E., Markham, C.H., Metter, E.J., et al. 1985. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington’s disease. In “Brain Imaging and Brain Function”. (Ed. L. Sokoloff). (Raven Press, New York), pp. 199–209
Kühl, D.E., Metter, E.J. and Riege, W.H. 1984a. Patterns of local cerebral glucose utilization determined in Parkinson’s disease by the 18-F-Fluorodeoxyglucose method. Ann. Neurol., 15 419–424.
Kühl, D.E., Metter, E.J., Riege, W.H., et al. 1984b. Patterns of cerebral glucose utilization in Parkinson’s disease and Huntington’s disease. Ann. Neurol., 15, (Suppl. 1), 119–125.
Kuhl, D.E., Phelps, M.E., Markham, C.H., et al. 1982. Cerebral metabolism and atrophy in Huntington’s disease determined by 18-FDG and computed tomographic scan. Ann. Neurol., 12, 425–434.
Leenders, K.L. (Ed.) 1986. Movement disorders: A study with positron emission tomography. (Thesis, Rodopi Press, Amsterdam).
Leenders, K., Wolfson, L., Gibbs, J., et al. 1985. Regional cerebral blood flow and oxygen metabolism in Parkinson’s disease and their response to L-Dopa. J. Cereb. Blood Flow Metab., 5 (Suppl. 1), 488–489.
Martin, W.R.W. 1985. Positron emission tomography in movement disorders. Can. J. Neurol. Sci., 12, 6–10.
Martin, W.R.W., Beckman, J.H., Calne, C.B., et al. 1984a. Cerebral glucose metabolism in Parkinson’s disease. Can. J. Neurol. Sci., 11, 169–173.
Martin, W.R.W., Hayden, M.R., Suchowersky, 0., et al. 1984b. Striatal metabolism in Huntington’s disease and benign hereditary chorea. Ann. Neurol., 16, 126.
Mazziotta, J.C., Wapensky, J., Phelps, M.E., et al. 1985. Cerebral glucose utilization and blood flow in Huntington’s disease: symptomatic and at-risk subjects. J. Cereb. Blood Flow Metab., 5, (Suppl. 1), 25–26.
Melamed, E., Lavy, S., Cooper, G., et al. 1978. Regional cerebral blood flow in Parkinsonism. Measurement before and after Levodopa. J. Neurol. Sci., 38, 391–397.
Perlmutter, J.S. and Raichle, M.E. 1985. Reduced blood flow in the frontal mesocortex in Parkinsonian patients. J. Cereb. Blood Flow Metab., 5, (Suppl. 1), 171–172.
Perlmutter, J.S. and Raichle, M.E. 1984. Pure hemidystonia with basal ganglion abnormalities in positron emission tomography. Ann. Neurol., 15, 228–233.
Porrino, L.J., Burns, R.S., Crane, A.M., et al. 1985. Measurement of local cerebral glucose metabolism in a primate model of Parkinsonism. J. Cereb. Blood Flow Metab., 5, (Suppl. 1), 167–168.
Raichle, M.E., Perlmutter, J.S. and Fox, P.T. 1984. Parkinson’s disease: metabolic and pharmacological approaches with positron emission tomography. Ann. Neurol., 3 (Suppl. 1), 131–132.
Rougemont, D., Baron, J.C., Collard, P., et al. 1983. Local cerebral metabolic rate of glucose (ICMRGlc) in treated and untreated patients with Parkinson’s disease. J. Cereb. Blood Flow Metab., 3, (Suppl. 1), 504–505.
Rougemont, D., Baron, J.C, Collard, P., et al. 1984. Local cerebral glucose utilisation in treated and untreated patients with Parkinson’s disease. J. Neurol., Neurosurg., Psychiat., 47, 824–830.
Schwartz, W.J., Sharp, F.R., Gunn, R.H., et al. 1976. Lesions of ascending dopaminergic pathways decrease forebrain glucose uptake. Nature, 261, 155–157.
Stoessl, A.J. Martin, W.R.W., Clark, C., et al. 1986. PET studies of cerebral glucose metabolism in idiopathic torticollis. Neurology, 36, 653–657.
Wolfson, L.I., Leenders, K.L., Brown, L.L., et al. 1985. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology, 35, 1399–1405.
Wooten, G.F. and Collins, R.C. 1981. Metabolic effects of unilateral lesions of the substantia nigra. J. Neuro Sci., 1 285–291.
Young, A.B., Penney, J.B., Starosta-Rubinstein, S., et al. 1986. PET scan investigations of Huntington’s disease: cerebral metabolic correlates of neurological features and functional decline. Ann. Neurol., 20, 296–303.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 ECSC, EEC, EAEC, Brussels-Luxembourg
About this chapter
Cite this chapter
Schuier, F.J. (1987). Changes of Cerebral Glucose Metabolism in Movement Disorders. In: Heiss, WD., Pawlik, G., Herholz, K., Wienhard, K. (eds) Clinical efficacy of positron emission tomography. Developments in Nuclear Medicine, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3345-3_8
Download citation
DOI: https://doi.org/10.1007/978-94-009-3345-3_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8002-6
Online ISBN: 978-94-009-3345-3
eBook Packages: Springer Book Archive